NBIX vs. SPY
Compare and contrast key facts about Neurocrine Biosciences, Inc. (NBIX) and SPDR S&P 500 ETF (SPY).
SPY is a passively managed fund by State Street that tracks the performance of the S&P 500 Index. It was launched on Jan 22, 1993.
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: NBIX or SPY.
Correlation
The correlation between NBIX and SPY is 0.38, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.
Performance
NBIX vs. SPY - Performance Comparison
Key characteristics
NBIX:
-0.58
SPY:
0.30
NBIX:
-0.54
SPY:
0.56
NBIX:
0.91
SPY:
1.08
NBIX:
-0.55
SPY:
0.31
NBIX:
-1.34
SPY:
1.40
NBIX:
17.72%
SPY:
4.18%
NBIX:
40.94%
SPY:
19.64%
NBIX:
-97.21%
SPY:
-55.19%
NBIX:
-33.86%
SPY:
-13.86%
Returns By Period
In the year-to-date period, NBIX achieves a -25.73% return, which is significantly lower than SPY's -9.91% return. Over the past 10 years, NBIX has underperformed SPY with an annualized return of 8.81%, while SPY has yielded a comparatively higher 11.59% annualized return.
NBIX
-25.73%
-8.10%
-14.09%
-23.51%
0.49%
8.81%
SPY
-9.91%
-6.90%
-9.38%
6.72%
14.62%
11.59%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Risk-Adjusted Performance
NBIX vs. SPY — Risk-Adjusted Performance Rank
NBIX
SPY
NBIX vs. SPY - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for Neurocrine Biosciences, Inc. (NBIX) and SPDR S&P 500 ETF (SPY). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Dividends
NBIX vs. SPY - Dividend Comparison
NBIX has not paid dividends to shareholders, while SPY's dividend yield for the trailing twelve months is around 1.36%.
| TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
NBIX Neurocrine Biosciences, Inc. | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
SPY SPDR S&P 500 ETF | 1.36% | 1.21% | 1.40% | 1.65% | 1.20% | 1.52% | 1.75% | 2.04% | 1.80% | 2.03% | 2.06% | 1.87% |
Drawdowns
NBIX vs. SPY - Drawdown Comparison
The maximum NBIX drawdown since its inception was -97.21%, which is greater than SPY's maximum drawdown of -55.19%. Use the drawdown chart below to compare losses from any high point for NBIX and SPY. For additional features, visit the drawdowns tool.
Volatility
NBIX vs. SPY - Volatility Comparison
Neurocrine Biosciences, Inc. (NBIX) has a higher volatility of 17.47% compared to SPDR S&P 500 ETF (SPY) at 14.52%. This indicates that NBIX's price experiences larger fluctuations and is considered to be riskier than SPY based on this measure. The chart below showcases a comparison of their rolling one-month volatility.